Constipation Clinical Trial
Official title:
The Drink Milk Consumption Benefits With Culture Probiotic in the Treatment of Constipation Women
Constipation is defined as a disorder characterized by persistent difficulty to evacuate or a feeling of incomplete evacuation and / or infrequent bowel movements. Many factors contribute to the onset of constipation, such as changes in dietary intake and fluid intake, decrease in consumption of products containing fiber, intake of drugs or laxatives, decreased intestinal motility and physical inactivity. The objective was to evaluate the effect of consumption of dairy products with probiotics on constipation. Randomized double-blind clinical trial in the city of Bom Retiro do Sul / RS, Brazil. They were recruited 60 female patients aged 20-50 years after application of the Rome III criteria (World Gastroenterology Organization, 2010) and Range Bristol (World Gastroenterology Organisation, 2010) were diagnosed with constipation. Patients were randomized into two groups, where one group will receive the milk drink with probiotics and the other group will receive a probiotic milk drink without (control group). The milk beverage consumption period shall be 60 days where each patient will consume 150 ml of milk drink a day, with breakfast or morning snack.
Randomized double blind clinical trial conducted at the health center of the city of Bom
Retiro do Sul / RS, Brazil, from December 2014 to March 2015. The study began after approval
by the Ethics Committee of the Research Center University Univates (COEP), Lajeado. Brazil.
They were recruited 60 female patients aged 20-50 years after application of the Rome III
criteria (World Gastroenterology Organization, 2010) and Range Bristol (World
Gastroenterology Organisation, 2010) were diagnosed with constipation. Patients were
randomized into two groups, where one group will receive the milk drink with probiotics and
the other group will receive a probiotic milk drink without (control group). The milk
beverage consumption period shall be 60 days where each patient will consume 150 ml of milk
drink a day, with breakfast or morning snack. The milk drink was provided in the homes of
participants and the health center of the city of Bom Retiro do Sul once a week. At the
beginning of treatment and at the end of treatment that will last 60 days, will be delivered
to Bristol Scale and the criteria of Rome III, so as to verify the improvement or not of
constipation. Patients who agree to participate in the study signed a consent form IC. Will
be the orientation for the volunteers not to consume yogurt and other cultured milks with
probiotics, will also be oriented to maintain the same diet and lifestyle when they were
constipated, thus, check for improvement in constipation with the use of probiotics .
Inclusion criteria: Having a diagnosis of constipation; Be aged between 20 and 50 years;
being female.
Data collection brings no risk or damage to entrant, but can cause discomfort and
embarrassment to meet the criteria of Rome III and Bristol Scale and the time that will have
to spend 10 to 15 minutes. Such issues will be mitigated by the fact that the interview be
individualized and the participant have at their disposal a private room to answer the
questionnaires, only with the presence of the academic.
Participants will not obtain any financial benefit, only the benefits of milk drink with
probiotics and how much consumption adds to your health. It is also important to note that
participation in the study will not result in expenses.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Recruiting |
NCT06292949 -
Clinical Study of Resistant Starch in Improving Constipation
|
N/A | |
Recruiting |
NCT04132661 -
MRI Assessment of Mode of Action of Bisacodyl, Single Dose
|
Phase 4 | |
Terminated |
NCT02839889 -
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
|
Phase 4 | |
Completed |
NCT02726295 -
The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study
|
Phase 4 | |
Recruiting |
NCT02255747 -
Anal Dilatation for Infants and Children With Constipation
|
N/A | |
Completed |
NCT02246647 -
Biomarkers for Intestinal Permeability in Patients With Constipation
|
||
Completed |
NCT01566409 -
Maintenance Treatment for Children With Constipation
|
N/A | |
Completed |
NCT02658201 -
Ultrafast MRI Imaging to Exclude Constipation
|
N/A | |
Completed |
NCT01695915 -
Diurnal Variation in Rectal Diameter
|
N/A | |
Completed |
NCT01710579 -
Normal Values in Ano-rectal 3D High Resolution Manometry
|
N/A | |
Completed |
NCT02863848 -
Effect of Inulin-type Fructans on Constipated Children.
|
N/A | |
Completed |
NCT01474499 -
A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation
|
Phase 3 | |
Completed |
NCT01438567 -
A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy
|
Phase 3 | |
Completed |
NCT01411501 -
Efficacy and Safety of Acupuncture for Functional Constipation
|
Phase 3 | |
Completed |
NCT01170039 -
The Effectiveness of Lubiprostone in Constipated Diabetics
|
Phase 4 | |
Completed |
NCT00931853 -
Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).
|
Phase 3 | |
Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
Terminated |
NCT01003249 -
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
|
Phase 4 | |
Completed |
NCT00994851 -
Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment.
|
Phase 3 |